TNFSF11 and breast cancer: We identify RANKL, secreted by osteoblasts in response to sympathetic activation, as a stimulatory factor for breast cancer cell migration and bone colonization in vivo and demonstrate that breast cancer metastasis to bone, induced by increased endogenous sympathetic outflow triggered by restraint stress, can be inhibited by the β-blocker propranolol.